These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The two meanings of how and the gene patenting debate. Evans JH Am J Bioeth; 2002; 2(3):26-8. PubMed ID: 12230851 [No Abstract] [Full Text] [Related]
4. Intellectual property and products of nature. Sagoff M Am J Bioeth; 2002; 2(3):12-3. PubMed ID: 12230841 [No Abstract] [Full Text] [Related]
5. Faculty and employee ownership of inventions in Australia. McBratney A; Tarr JA Nat Biotechnol; 2010 Oct; 28(10):1019-22. PubMed ID: 20944586 [TBL] [Abstract][Full Text] [Related]
6. Intellectual property. University licensing and the Bayh-Dole Act. Thursby JG; Thursby MC Science; 2003 Aug; 301(5636):1052. PubMed ID: 12933996 [No Abstract] [Full Text] [Related]
7. Enclosing the genome: what squabbles over genetic patents could teach us. Boyle J Adv Genet; 2003; 50():97-122; discussion 507-10. PubMed ID: 14714688 [No Abstract] [Full Text] [Related]
8. No patents for semantic information. Wilson J Am J Bioeth; 2002; 2(3):15-6. PubMed ID: 12230843 [No Abstract] [Full Text] [Related]
9. Bayh-Dole: if we knew then what we know now. Boettiger S; Bennett AB Nat Biotechnol; 2006 Mar; 24(3):320-3. PubMed ID: 16525405 [No Abstract] [Full Text] [Related]
10. Steady the course: property rights in genetic material. Epstein RA Adv Genet; 2003; 50():153-94; discussion 507-10. PubMed ID: 14714690 [No Abstract] [Full Text] [Related]
11. Does the pharmaceutical sector have a coresponsibility for the human right to health? Schroeder D Camb Q Healthc Ethics; 2011 Apr; 20(2):298-308. PubMed ID: 21435305 [No Abstract] [Full Text] [Related]
12. Intellectual property rights in genes and gene fragments: a registration solution for expressed sequence tags. Holman MA; Munzer SR Iowa Law Rev; 2000 Mar; 85(3):735-848. PubMed ID: 16523593 [No Abstract] [Full Text] [Related]
13. Diagnostics firms face new patent claim worries. Allison M Nat Biotechnol; 2009 Jul; 27(7):586-7. PubMed ID: 19587651 [No Abstract] [Full Text] [Related]
14. Patent eligibility of stem cells in Europe: where do we stand after 8 years of case law? Storz U; Faltus T Regen Med; 2017 Jan; 12(1):37-51. PubMed ID: 27976982 [TBL] [Abstract][Full Text] [Related]
15. Intellectual property rights in agriculture in the light of the debate on biotechnology: historical evolution and current situation. Gimelli F Ital J Biochem; 2000; 49(3-4):41-51. PubMed ID: 11508056 [No Abstract] [Full Text] [Related]
16. Intellectual property protection for plant-related inventions in Europe. Fleck B; Baldock C Nat Rev Genet; 2003 Oct; 4(10):834-8. PubMed ID: 14526379 [TBL] [Abstract][Full Text] [Related]
17. Intellectual property and access to ART: unwise choice of terminology. Stallman R PLoS Med; 2006 Nov; 3(11):e509; author reply e510. PubMed ID: 17132062 [No Abstract] [Full Text] [Related]
18. Japanese forum urges rethink over patents. Cyranoski D Nature; 2002 Jan; 415(6870):354. PubMed ID: 11807511 [No Abstract] [Full Text] [Related]
19. Designing an optimal intellectual property system for plants: a US Supreme Court debate. Janis MD; Kesan JP Nat Biotechnol; 2001 Oct; 19(10):981-3. PubMed ID: 11581668 [No Abstract] [Full Text] [Related]
20. Patent law in dentistry: an overview. Bijle MN Indian J Dent Res; 2011; 22(4):574-9. PubMed ID: 22124055 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]